Summary
59 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 64% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 4.1 years of operating profit.
- Out of every 100 JPY of revenue, only 2.1 JPY is left as net profit.
- It earns only 3.8 JPY a year on every 100 JPY of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.6 JPY for 1 JPY of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (JPY)
Diluted EPS (JPY)
Revenue grew by 19% a year over 5 years. Over the last 3 years it grew by 17% a year. Earnings per share grew by 64% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 JPY of revenue goes
- Cost of sales 89 JPY
- Sales and administration 8.2 JPY
- Taxes and other 0.4 JPY
- Net profit 2.1 JPY
Net profit, industry median (Medical - Care Facilities) 6.7 JPY
Out of every 100 JPY of revenue, 2.1 JPY is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail